Reactive astrocytes are a prominent feature in many of the leukodystrophies, and whether changes in CSF and/or blood levels of GFAP suggest utility as a biomarker for these conditions is just beginning as a topic for investigation. The gene discussed is GFAP; the disease is leukodystrophy.